KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Working Capital Changes (2016 - 2025)

Amgen has reported Other Working Capital Changes over the past 17 years, most recently at $577.0 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $577.0 million for Q4 2025, up 4021.43% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 94.33% YoY), and the annual figure for FY2025 was $1.3 billion, up 94.33%.
  • Other Working Capital Changes for Q4 2025 was $577.0 million at Amgen, up from $283.0 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for AMGN hit a ceiling of $577.0 million in Q4 2025 and a floor of -$241.0 million in Q2 2022.
  • Median Other Working Capital Changes over the past 5 years was $127.0 million (2021), compared with a mean of $123.1 million.
  • Biggest five-year swings in Other Working Capital Changes: crashed 315.18% in 2022 and later surged 4021.43% in 2025.
  • Amgen's Other Working Capital Changes stood at -$136.0 million in 2021, then skyrocketed by 32.35% to -$92.0 million in 2022, then surged by 352.17% to $232.0 million in 2023, then plummeted by 93.97% to $14.0 million in 2024, then surged by 4021.43% to $577.0 million in 2025.
  • The last three reported values for Other Working Capital Changes were $577.0 million (Q4 2025), $283.0 million (Q3 2025), and $206.0 million (Q2 2025) per Business Quant data.